The impact of insulin pump therapy on glycaemic profile of patients with type 2 diabetes: data from the OpT2mise study

被引：0
|
作者：
Conget, I. [1 ,2 ]
Cohen, O. [3 ]
Aronson, R. [4 ]
Castaneda, J. [5 ]
Re, R. [5 ]
Shin, J. [5 ]
Reznik, Y. [6 ]
机构：
[1] Hosp Clin Barcelona, Dept Endocrinol, Diabet Unit, Barcelona, Spain
[2] Univ Barcelona, Barcelona, Spain
[3] Ch Sheba Med Ctr, Inst Endocrinol, Tel Hashomer, Israel
[4] LMC Diabet & Endocrinol, Toronto, ON, Canada
[5] Medtronic, Northridge, CA USA
[6] Ctr Hosp Reg Univ Caen Cote de Nacre, Dept Endocrinol & Diabet, Caen, France
来源：
DIABETOLOGIA | 2014年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1012
引用
收藏
页码：S416 / S416
页数：1
相关论文
共 50 条
  • [1] THE IMPACT OF INSULIN PUMP THERAPY ON GLYCEMIC PROFILE OF PATIENTS WITH TYPE 2 DIABETES. DATA FROM THE OPT2MISE STUDY
    Conget, I.
    Cohen, O.
    Aronson, R.
    Castaneda, J.
    Runzis, S.
    Huang, S.
    Shin, J.
    Reznik, Y.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2015, 17 : A33 - A33
  • [2] The Impact of Insulin Pump Therapy on Glycemic Profiles in Patients with Type 2 Diabetes: Data from the OpT2mise Study
    Conget, Ignacio
    Castaneda, Javier
    Petrovski, Goran
    Guerci, Bruno
    Racault, Anne-Sophie
    Reznik, Yves
    Cohen, Ohad
    Runzis, Sarah
    de Portu, Simona
    Aronson, Ronnie
    DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 (01) : 22 - 28
  • [3] Efficacy and safety of insulin pump therapy in type 2 diabetes: the OpT2mise study
    Reznik, Y.
    Cohen, O.
    Aronson, R.
    Runzis, S.
    Castaneda, J.
    De Portu, S.
    Lee, S.
    Conget, I.
    DIABETOLOGIA, 2014, 57 : S410 - S411
  • [4] Efficacy and Safety of Insulin Pump Therapy in Type 2 Diabetes: The OpT2mise Study
    Aronson, Ronnie
    Reznik, Yves
    Conget, Ignacio
    Runzis, Sarah
    Castaneda, Javier
    De Portu, Simone
    Lee, Scott
    Cohen, Ohad
    DIABETES, 2015, 64 : A270 - A271
  • [5] OpT2mise study: the impact of insulin pump therapy on treatment satisfaction and resource utilisation in patients with type 2 diabetes
    Aronson, R.
    Cohen, O.
    Conget, I.
    de Portu, S.
    Racault, A-S.
    Shin, J.
    Reznik, Y.
    DIABETOLOGIA, 2014, 57 : S415 - S415
  • [6] OPT2MISE STUDY: THE IMPACT OF INSULIN PUMP THERAPY ON TREATMENT SATISFACTION AND RESOURCE UTILIZATION IN PATIENTS WITH TYPE 2 DIABETES
    Aronson, R.
    De Portu, S.
    Cohen, O.
    Conget, I.
    Racault, A. S.
    Shin, J.
    Runzis, S.
    Reznik, Y.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2015, 17 : A11 - A11
  • [7] EFFICACY AND SAFETY OF INSULIN PUMP THERAPY IN TYPE 2 DIABETES: OPT2MISE STUDY - FULL STUDY REPORT
    Aronson, R.
    Reznik, Y.
    Conget, I.
    Runzis, S.
    De Portu, S.
    Lee, S.
    Castaneda, J.
    Cohen, O.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A41 - A41
  • [8] Contribution of basal and postprandial hyperglycaemia in type 2 diabetes patients treated by an intensified insulin regimen: Impact of pump therapy in the OPT2mise trial
    Reznik, Yves
    Habteab, Aklilu
    Castaneda, Javier
    Shin, John
    Joubert, Michael
    DIABETES OBESITY & METABOLISM, 2018, 20 (10): : 2435 - 2441
  • [9] Efficacy and safety after 1 year of insulin pump therapy in type 2 diabetes: the OpT2mise Study continuation phase
    Reznik, Y.
    Aronson, R.
    Conget, I.
    Runzis, S.
    Racault, A. -S.
    Castaneda, J.
    Lee, S. W.
    Cohen, O.
    DIABETOLOGIA, 2015, 58 : S477 - S478
  • [10] Factors affecting the Insulin Dose Adaptation in Patients with Diabetes Mellitus Type 2: an Analysis from the OpT2mise Study
    Schuetz-Fuhrmann, Ingrid
    Reznik, Yves
    Aronson, Ronnie
    Conget, Ignacio
    Liabat, Severine
    Prager, Rudolf
    Castaneda, Javier
    Cohen, Ohad
    WIENER KLINISCHE WOCHENSCHRIFT, 2016, 128 : S401 - S401
12345